This study was carried out to check the efficacy of empagliflozin in heart failure patients. For...
Author - Hippocrates Briefs Team
VISUALIZED: Trial Study to Show Empagliflozin Outcomes In...
Read further: Trial Study to Show Empagliflozin Outcomes In Patients of Chronic Heart Failure and...
Trial to Study Comprehensive Lifestyle Intervention for...
Eligible asymptomatic individuals between the age range 40-50 years from the progression of early...
Hemodynamic Trial Study to Show Riociguat Outcomes In Patients...
The DYNAMIC trial study was a randomized, multicenter, placebo-controlled, double-blind IIB trial...
Study to Explore Cangrelor vs. Glycoprotein IIa/IIb Inhibitors...
During dual antiplatelet therapy, Cangrelor or eptifibatide, etc., short-acting parental...
VISUALIZED: Early Rhythm Control Therapy Effects With Atrial...
Read further: Early Rhythm Control Therapy Effects With Atrial Fibrillation
Links Found Between COVID-19 Post-Recovery and Incident Heart...
To investigate the related events surrounding COVID-19 post-recovery and the development of de novo...
Improved Outcomes In Age-Irrespective Heart Failure and...
While it is known that empagliflozin plays a vital role in reducing cardiovascular death (CVD) or...
ARNI vs. ACEi In Reducing Heart Failure Events Post-Myocardial...
Angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are drugs...
AHA Construct of Cardiovascular Health: Life’s Essential 8
The American Heart Association (AHA) worked on cardiovascular health, and in 2010 they defined a...